02.09.2020
New Board of Directors
August 20th 2020   August 20th 2020 Regenics AS General Assembly June 24th 2020 has nominated a new Board of Directors: Tore Heldrup Rasmussen, reelected Wilhelm Holst, reelected Harald Nordal, new Jan Alfheim, new On the new Boards...
01.08.2020
Regenics new office at Oslo Science Park
August 1st 2020  Regenics AS expands its laboratory footprint with new lab space at ShareLab at Forkningsparken, Oslo.   
17.06.2020
Annual Meeting 2020
June 24th 2020 Notice of Annual Meeting took place June 24th 2020 at 16.00. Companys site Karvesvingen 2. 
17.06.2020
AquaHeal 3D update (EU funded project)
Regenics updates on the 17.3 mill NOK coordination of EU BlueBio Cofund R&D project. RISE (Swe) and Charles River (US) partners
24.03.2020
Regenics AS secures loan from Innovation Norway
Regenics AS secures loan facility from Innovation Norway
01.01.2020
Regenics awarded 17.3 mill NOK to coordinate EU BlueBio Cofund R&D project
Regenics awarded 17.3 mill NOK to coordinate EU BlueBio Cofund R&D project. RISE (Swe) and Charles River (US) partners
25.09.2019
Board Meeting No 6 2019
Board Meeting No 6. September 25th 2019
12.08.2019
US Patent - Notice of Allowance
US patent - Notice of Allowance
23.07.2019
Canadian Patent - Notice of Allowance
Canadian Patent - Notice of Allowance
25.06.2019
Board Meeting No 5 2019
Board Meeting No 5. June 25th 2019
25.06.2019
Notice and Protocol Annual Meeting 2019
June 25th 2019 Notice of Annual Meeting June 25th 2019. The Annual Meeting 2019 will take place at the Companys site Karvesvingen 2. 2, Oslo from 2 pm to 5 pm.
25.06.2019
Annual Report 2018
Regenics post a positive 2018 result of 1.72 mill NOK. 
13.06.2019
3D-bioprinting - ERA-NET BlueBio Joint Transnational Call 2019
BlueBio Joint Transnational Call 2019
08.05.2019
Board Meeting No 4 2019
Board Meeting No 4 2019, May 8th 2019
18.04.2019
Paragon Nordic AB - Collaboration
Paragon Nordic AB - Collaboration
13.03.2019
Patent annuities paid 2019
Regenics patents due for annuity/fee payments in May 2019 have been paid and continued by our patent legal consultant.

Page 1 of 7   >  >>

REGENICS AT SCIENCE EVENTS

June 17-19th 2019

The Smart Patient. Regenics (CEO H.Lund co-chair)

Program 2019

December 15th 2018

DnB Healtcare Conference 2018

 

October 5-6th 2018

Wound Healing and Skin Diseaes, Los Angeles (CEO H.Lund keynote invitation)

June 19th – 20th 2018

Conference Biotech-Medtech-Expo, Stavanger (CEO H.Lund co-chair)

Program (tbd)

 

June 5-6th 2017

Investor Conference Biotech-Medtech, Stavanger (CEO co-chair)

Program (tbd)

March 9th 2017

Roundtable Conference in investing in Biotech, CEO Henrik Lund, moderator for the Event at Stavanger Forum Oslo

Program Roundtable Conference Stavanger

March 8th 2017

War on Cancer Nordics, CEO Henrik Lund in closing panel at the Economist Event in Oslo

Program Economist Event Oslo

December 15th 2016

DnB Healtcare Conference 2016, CMO Christian Clemm provides company update in the ventture session

Regenics presentation

October 19-20-21 2016

Biomarine Convention, CEO Henrik Lund, participating at Convention in Oslo

Program Biomarine Business Conference

October 19th 2016

DnB Next at Oslo Innovation Week, CSO Gry Lønne, presenting Regenics Company update in Oslo

program DNB Next healthcare Regenics presentation

September 25-28 2016

At the 4th Congress on Innovation in Drug Delivery in Antibes, Regenics presented abstract.

Abstract 4th Congress on Innovation in Drug Delivery

October 22-24 2015

Joint Meeting of the European Tissue Repair Society (ETRS) and the Wound Healing Society (WHS), Regenics presented abstract

Abstract 7th ETRS-WHS meeting

Regenics AS has developed a number of assays and techniques to study effects of various substances on skin cells both in vitroin vivo and in the clinic. Our focus is to develop products and techniques for therapeutic skin applications and to improve skin appearance.